Bicycle Therapeutics (BCYC) Other financing activities (2018 - 2026)
Bicycle Therapeutics' (BCYC) quarterly Other financing activities came in at $1000.0 in Q2 2026, little changed YoY from $1000.0 in Q2 2025, and down 91.67% on a QoQ basis from $12000.0 in Q1 2026.
Bicycle Therapeutics (BCYC) Other financing activities (2018 - 2026) Analysis & Trends
Bicycle Therapeutics (BCYC) has 9 years of Other financing activities data on file, last reported at $1000.0 in Q2 2026.
- Quarterly Other financing activities changed 0.0% year-over-year to $1000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $47000.0 (down 95.95% YoY) and the FY2025 annual result came in at $37000.0, down 99.51% from the prior year.
- Other financing activities slipped to $1000.0 in Q2 2026, from $12000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $4.5 million in Q2 2024 to a low of $1000.0 in Q2 2025.
- A 5-year average of $513833.3 and a median of $162000.0 in 2022 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2024 — Other financing activities jumped 93450.0% — and 2025, when it plunged 99.98%.
- Tracing BCYC's Other financing activities over 5 years: stood at $185000.0 in 2022, then surged by 103.24% to $376000.0 in 2023, then slumped by 34.84% to $245000.0 in 2024, then sank by 86.53% to $33000.0 in 2025, then sank by 96.97% to $1000.0 in 2026.
- The last three Other financing activities figures came in at $1000.0 (Q2 2026), $12000.0 (Q1 2026), and $33000.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Bicycle Therapeutics | 272.28 Mn | 272.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Jun 30, 2026 | 1,000.00 |
| Mar 31, 2026 | 12,000.00 |
| Mar 31, 2026 | 12,000.00 |
| Dec 31, 2025 | 33,000.00 |
| Dec 31, 2025 | 33,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 245,000.00 |
| Dec 31, 2024 | 245,000.00 |
| Sep 30, 2024 | 912,000.00 |
| Sep 30, 2024 | 912,000.00 |
| Jun 30, 2024 | 4.50 Mn |
| Jun 30, 2024 | 4.50 Mn |
| Mar 31, 2024 | 1.87 Mn |
| Mar 31, 2024 | 1.87 Mn |